Penumbra
PEN
#1691
Rank
C$17.90 B
Marketcap
C$454.26
Share price
0.83%
Change (1 day)
19.56%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Total debt

Total debt on the balance sheet as of June 2026 : C$0.30 Billion

According to Penumbra's latest financial reports the company's total debt is C$0.30 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Penumbra - Total debt on balance sheet (from 2018 to 2026)

Total debt by year

Year Total debt Change
2025-12-31C$0.30 B-6.14%
2024-12-31C$0.32 B3.13%
2023-12-31C$0.31 B-2.85%
2022-12-31C$0.31 B44.65%
2021-12-31C$0.22 B124.47%
2020-12-31C$98.53 M-8.33%
2019-12-31C$0.10 B
2018-12-31N/A
2013-12-31C$6.38 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Merit Medical
MMSI
C$1.15 B 285.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Inari Medical
NARI
C$46.18 M-84.62%๐Ÿ‡บ๐Ÿ‡ธ USA